Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

Biome leaps into Canada as sales in Australia skyrocket

  • In News
  • November 14, 2024
  • Gracen Moore
Biome leaps into Canada as sales in Australia skyrocket

Biome Australia (ASX: BIO), a healthcare business specialising in developing, marketing, and distributing probiotic and complementary health products, has spread its wings into the Canadian market after generating positive feedback and encouraging early sales during a two-month testing period.

Management believes the Canadian market is now adequately derisked for the company to march forward with a broadened brand launch for its flagship line of products, Activated Probiotics. Effective immediately, it will target independent pharmacies, health food merchants, and health practitioners within the nation.

In turn, Biome has engaged the services of its first ‘practitioner education consultant’ in the Canadian province of Ontario, who is tasked with collaborating with partner sales staff to help penetrate the market.

The group’s expansion into Canada has been further aided by a recent tick of approval from Health Canada – the government department responsible for national health policy – for three of Biome’s products. All up, 12 of the company’s 17 products have now received the go-ahead in the country. 

Biome Australia managing director and founder, Blair Vega Norfolk, said:

“I am very pleased with the initial reaction of how Activated Probiotics has been received in the Canadian market by customers, retailers and health professionals alike. We view this market and region to be of key strategic importance for Biome’s future.”

Separately, sales of Activate Probiotics in Australia continue to soar with the company reporting a new record high of 188,000 units in sell-through over the most recent rolling three-month period. This represents a lift of about 60 per cent from the same time last year.

Management noted that this outcome relates to units purchased by customers from Biome’s wholesale partners, a critical metric that brings to light the growing demand for the Active Probiotics brand in the Australian market.

Meanwhile, sales of Activated Probiotics from Australia’s largest pharmacy group, Terry White Chemmart, also reached a new record of $3.5 million over the last twelve months through to October. This equates to a 75 per cent boost from a year ago.

The company added that Activated Probiotics has now become the number two brand in total revenue within the practitioner-only category, and the number one for growth.

Blair Vega Norfolk commented:

“The ongoing growth and development in our local market, Australia, has also been very encouraging. The Activated Probiotics brand continues to lead the way as one of the highest growth brands in Australia, with our established health retail partners reporting record sell-through and scan sales over the past few months.”

Biome reached an important milestone of becoming cash flow and operating earnings (EBITDA) positive in the second half of FY24, largely on the back of its growing presence in its core Australian market.

The company’s strategic plan – known as Vision 27 ‒ involves Biome maintaining its cash flow positive status and reinvesting a portion of its profits into growth initiatives, including international expansion. 

As part of this strategy, it has set a target of between $75 million and $85 million in total revenue over a cumulative three-year period from FY25 to FY27. For context, the company generated about $13 million in revenue during FY24.

A key ingredient of Vision 27 involves Biome replicating the business model it successfully applied in Australia and implementing it in targeted foreign markets. In Australia alone, revenue has risen from $830,000 in FY20 to $12.1 million in FY24.

More specifically, the company intends to leverage its skilled Australian workforce to support a cost-effective international expansion into markets with a high-growth profile.

Currently, Biome remains at the early stages of penetrating Ireland, New Zealand, the UK, and most recently Canada. It is also testing the waters of a full market entry into the Benelux nations of Belgium, Holland, and Luxembourg.

In FY24, revenue from international markets of about $900,000 nearly doubled from twelve months prior. 

  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens - July 29, 2025
  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology - July 24, 2025
  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S. - July 18, 2025
  •  
  •  
  •  
  •  
  • asx bio
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    February 5, 2025, 10:11 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/probiotics

    Reply
  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens - July 29, 2025
  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology - July 24, 2025
  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S. - July 18, 2025

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens - July 29, 2025
  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology - July 24, 2025
  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S. - July 18, 2025
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.